76 related articles for article (PubMed ID: 10743227)
1. [Mutation analysis of the p15 gene exon 2 in human primary hepatocarcinoma].
Qin Y; Li B; Tan Y; Sun Z; Sun Z; Zuo F
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Dec; 29(4):360-3. PubMed ID: 10743227
[TBL] [Abstract][Full Text] [Related]
2. [Study of deletion and mutation of p16 gene in primary hepatocellular carcinoma].
Qin Y; Chen J; Li B; Sun Z; Zuo F; Sun Z
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):492-4, 500. PubMed ID: 12528528
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
4. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
5. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas.
Tahara H; Smith AP; Gaz RD; Arnold A
J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
7. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
Fujishita T; Mizushima Y; Kashii T; Kobayashi M
Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the p15 and p16 genes in acute leukaemias.
Sill H; Aguiar RC; Schmidt H; Hochhaus A; Goldman JM; Cross NC
Br J Haematol; 1996 Mar; 92(3):681-3. PubMed ID: 8616035
[TBL] [Abstract][Full Text] [Related]
9. Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers.
Rusin MR; Okamoto A; Chorazy M; Czyzewski K; Harasim J; Spillare EA; Hagiwara K; Hussain SP; Xiong Y; Demetrick DJ; Harris CC
Int J Cancer; 1996 Mar; 65(6):734-9. PubMed ID: 8631583
[TBL] [Abstract][Full Text] [Related]
10. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.
Gao L; Liu L; van Meyel D; Cairncross G; Forsyth P; Kimmel D; Jenkins RB; Lassam NJ; Hogg D
Clin Cancer Res; 1997 Jun; 3(6):977-81. PubMed ID: 9815774
[TBL] [Abstract][Full Text] [Related]
11. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients.
Wong IH; Lo YM; Yeo W; Lau WY; Johnson PJ
Clin Cancer Res; 2000 Sep; 6(9):3516-21. PubMed ID: 10999738
[TBL] [Abstract][Full Text] [Related]
12. Infrequent somatic mutations of the p16 and p15 genes in human bladder cancer: p16 mutations occur only in low-grade and superficial bladder cancers.
Miyamoto H; Kubota Y; Fujinami K; Dobashi Y; Kondo K; Yao M; Shuin T; Hosaka M
Oncol Res; 1995; 7(7-8):327-30. PubMed ID: 8747595
[TBL] [Abstract][Full Text] [Related]
13. [Alteration of p15 and p16 gene in gastric cancer].
Fushida S; Yonemura Y; Kawamura T; Nojima N; Satoh T; Fujita H; Michiwa Y; Fujimura T; Nishimura G; Miwa K; Miyazaki I
Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():279-84. PubMed ID: 9263516
[TBL] [Abstract][Full Text] [Related]
14. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
Sonoda Y; Yoshimoto T; Sekiya T
Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
[TBL] [Abstract][Full Text] [Related]
15. [Impact of p16INK4A and p15INK4B on human hepatocellular carcinoma cell proliferation and apoptosis].
Qin Y; Liu JY; Li B; Peng WZ; Fu MD; Sun ZL; Sun ZF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):132-7. PubMed ID: 15079795
[TBL] [Abstract][Full Text] [Related]
16. Mutations of p16 and p15 tumor suppressor genes and replication errors contribute independently to the pathogenesis of sporadic malignant melanoma.
Matsumura Y; Nishigori C; Yagi T; Imamura S; Takebe H
Arch Dermatol Res; 1998 Apr; 290(4):175-80. PubMed ID: 9617435
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma.
Child FJ; Scarisbrick JJ; Calonje E; Orchard G; Russell-Jones R; Whittaker SJ
J Invest Dermatol; 2002 Jun; 118(6):941-8. PubMed ID: 12060387
[TBL] [Abstract][Full Text] [Related]
18. [Mutation analysis of the tumor suppressor gene PTEN/MMAC1/TEP1 in human hepatocellular carcinoma].
Zhang LN; Zha XL; Yu Q; He JY
Shi Yan Sheng Wu Xue Bao; 2000 Sep; 33(3):223-7. PubMed ID: 12549040
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of the INK4 family of genes in prostate carcinomas.
Park DJ; Wilczynski SP; Pham EY; Miller CW; Koeffler HP
J Urol; 1997 May; 157(5):1995-9. PubMed ID: 9112579
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage.
Nakagawa K; Conrad NK; Williams JP; Johnson BE; Kelley MJ
Oncogene; 1995 Nov; 11(9):1843-51. PubMed ID: 7478613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]